SCHEMBL7957722

SCHEMBL7957722

COC[C@H]1O[C@@H](Oc2ccc([N+](=O)[O-])cc2)[C@H](OC)[C@H]2OC(C)(C)O[C@H]21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.33
LMNA P02545 2/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
THRB P10828 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NT5E P21589 1/20 0.32
POLB P06746 1/20 0.31
BCL9 O00512 1/20 0.31
CTNNB1 P35222 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31
APP P05067 1/20 0.31
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957838 0.86 NT5E (0.47) ALDH1A1MAPTNT5E
SCHEMBL7957974 0.85 ALDH1A1 (0.41) ALDH1A1MAPTKDM4ENT5E
SCHEMBL7948147 0.84 ALDH1A1 (0.38) ALDH1A1MAPTKDM4ELMNATP53
SCHEMBL7962256 0.84 MAPT (0.40) ALDH1A1MAPTLMNATP53CYP3A4
SCHEMBL7962254 0.84 MAPT (0.40) ALDH1A1MAPTLMNATP53CYP3A4
SCHEMBL7957578 0.83 MAPT (0.39) ALDH1A1MAPTLMNATP53CYP3A4
SCHEMBL7955687 0.82 HPSE (0.42) ALDH1A1MAPT
SCHEMBL7955684 0.82 HPSE (0.42) ALDH1A1MAPT
SCHEMBL8319213 0.81 CYP1A2 (0.39) ALDH1A1MAPTNT5EBCL9CTNNB1
SCHEMBL7957573 0.81 CYP1A2 (0.39) ALDH1A1MAPTNT5EBCL9CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271342-B1 SERUM STABILITY; FOR TUMOR THERAPY BAYER AKTIENGESELLSCHAFT (DE) 2001-08-07 US disclosed
EP-0819135-B1 SUGAR-MODIFIED CYTOSTATICS BAYER AG (DE) 1999-11-17 EP disclosed